{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:22:04Z","timestamp":1790630524153,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T00:00:00Z","timestamp":1632009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T00:00:00Z","timestamp":1632009600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The number of persons infected with COVID-19 continues to increase with deaths reported daily across the globe. High income countries such as the US, the UK, Italy and Belgium have reported high COVID-19 related deaths but low-and-middle-income countries have recorded fewer deaths despite having poor healthcare system. This study aimed to investigate the association between malaria prevalence and COVID-19 mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>An ecological study was conducted with data from 195 countries. Spearman\u2019s correlation was used to test the association between the population variables and COVID-19 mortality. Generalized linear model with Poisson distribution was used to determine the significant predictors of COVID-19 mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There was a significant positive correlation between median age, life expectancy, 65+ mortality and COVID-19 mortality while malaria prevalence, sex ratio and cardiovascular mortality were negatively correlated with COVID-19 mortality. Malaria prevalence, life expectancy and mortality rate were significant on multivariate regression analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The results of this study support the hypotheses that there are reduced COVID-19 deaths in malaria endemic countries, although the results need to be proved further by clinical trials.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-021-06701-8","type":"journal-article","created":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T11:02:21Z","timestamp":1632049341000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The association between malaria prevalence and COVID-19 mortality"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6321-161X","authenticated-orcid":false,"given":"Michael U.","family":"Anyanwu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,19]]},"reference":[{"key":"6701_CR1","unstructured":"WHO. Coronavirus. 2020. www.who.int\/health-topics\/coronavirus. Accessed Jan 2021."},{"key":"6701_CR2","unstructured":"WHO. WHO Director-General\u2019s opening remark at the media briefing on COVID-19. 2020. www.who.int\/director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed Jan 2021."},{"key":"6701_CR3","unstructured":"Centers for Disease Control and Prevention C. Covid-19. 2020. www.cdc.gov\/coronavirus\/2019-ncov\/prevent-getting-sick\/how-covid-spreads.html. Accessed 2021."},{"key":"6701_CR4","unstructured":"World Health Organization W. Coronavirus disease. 2021. www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/advice-for-public. Accessed 2021."},{"key":"6701_CR5","doi-asserted-by":"crossref","unstructured":"World Health Organisation W. Covid-19. 2020. https:\/\/covid19.who.int\/table. Accessed 2021.","DOI":"10.4324\/9781003120254-3"},{"issue":"5589","key":"6701_CR6","first-page":"5589","volume":"17","author":"U Mitsuyoshi","year":"2020","unstructured":"Mitsuyoshi U, Katharina O, Yasutaka H, Taisuke A. BCG vaccination and mortality of COVID-19 across 173 countries: an ecological study. Int J Environ Res Public Health. 2020;17(5589):5589.","journal-title":"Int J Environ Res Public Health"},{"key":"6701_CR7","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/S0140-6736(06)69895-4","volume":"368","author":"CJ Murray","year":"2006","unstructured":"Murray CJ, Lopez AD, Chin B, Feehan D, Hill KH. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918\u201320 pandemic: a quantitative analysis. Lancet. 2006;368:2211\u20138.","journal-title":"Lancet"},{"key":"6701_CR8","first-page":"118","volume":"102","author":"L Yakubu","year":"2020","unstructured":"Yakubu L. Africa\u2019s low COVID-19 mortality rate: a paradox. Int J Infect Dis. 2020;102:118\u201322.","journal-title":"Int J Infect Dis"},{"key":"6701_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13054-020-02902-w","volume":"24","author":"G Deng","year":"2020","unstructured":"Deng G, Yin M, Chen X, Zeng F. Clinical determinants for fatality of 44,672 patients with COVID-19. Crit Care. 2020;24:179.","journal-title":"Crit Care"},{"key":"6701_CR10","unstructured":"Azhar M, Kiran K, Manish T, Rupesh S, Asif M. Comparative analysis revealed reduced spread of COVID-19 in malaria endemic countries. medRxiv. 2020."},{"key":"6701_CR11","doi-asserted-by":"publisher","DOI":"10.30875\/60123dd4-en","volume-title":"World malaria report 2020: 20 years of global progress and challenges","author":"World Health Organization W","year":"2020","unstructured":"World Health Organization W. World malaria report 2020: 20 years of global progress and challenges. Geneva: World Health Organization; 2020."},{"key":"6701_CR12","unstructured":"United Nations. UN World Population Prospects. 2020. https:\/\/data.un.org. Accessed 2 Jan 2021"},{"key":"6701_CR13","unstructured":"Our world in Data. Cardiovascular diseases. 2018. https:\/\/ourworldindata.org\/grapher\/cardiovascular-disease-death-rates?tab. Accessed 7 Jan 2021."},{"key":"6701_CR14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s12936-020-03541-w","volume":"19","author":"MIH Hussein","year":"2020","unstructured":"Hussein MIH, Albashir AAD, Elawed OAMA. Malaria and COVID-19: unmasking their ties. Malar J. 2020;19:457.","journal-title":"Malar J"},{"issue":"4","key":"6701_CR15","first-page":"1138","volume":"8","author":"EN Pietro","year":"2020","unstructured":"Pietro EN, Matteo N. Global spread of coronavirus disease 2019 and malaria: An epidemiological paradox in the early stage of a pandemic. J Clin Med. 2020;8(4):1138.","journal-title":"J Clin Med"},{"issue":"2","key":"6701_CR16","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2174\/156652406776055221","volume":"6","author":"L Schofield","year":"2006","unstructured":"Schofield L, Mueller I. Clinical immunity to malaria. Curr Mol Med. 2006;6(2):205\u201321.","journal-title":"Curr Mol Med"},{"issue":"5","key":"6701_CR17","doi-asserted-by":"publisher","first-page":"945","DOI":"10.4269\/ajtmh.14-0444","volume":"95","author":"AL Bustinduy","year":"2015","unstructured":"Bustinduy AL, et al. Age strattified profiles of serum IL-6, IL-10, and TNF-alpha cytokines among Kenyan children with schistosoma haematobium, plasmodium falciparum and other chronic parasitic co-infections. Am J Trop Med Hyg. 2015;95(5):945\u201351.","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"6701_CR18","first-page":"1","volume":"2018","author":"TH Teo","year":"2018","unstructured":"Teo TH, et al. Plasmodium co-infection protects against chikungunya virus induced pathogies. Nat Commun. 2018;2018(9):1.","journal-title":"Nat Commun"},{"key":"6701_CR19","doi-asserted-by":"crossref","unstructured":"Hoffmann M, Kleine-Weber H, Kruger N, Muller M, Drosten C, Pohlmann S. The novel coronavirus 2019 uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv. 2020.","DOI":"10.1101\/2020.01.31.929042"},{"key":"6701_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.femsim.2004.01.010","volume":"41","author":"N Rasti","year":"2004","unstructured":"Rasti N, Wahlgren M, Chen Q. Molecular aspects of malaria pathogenesis. FEMS ImmunolMed Microbiol. 2004;41:9\u201326.","journal-title":"FEMS ImmunolMed Microbiol"},{"key":"6701_CR21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.meegid.2010.01.009","volume":"10","author":"G Dhangadamajhi","year":"2010","unstructured":"Dhangadamajhi G, Mohapatra BN, Kar SN, Ranjit M. Gene polymorphisms in angiotensin 1 converting enzyme (ACE1\/D) and angiotensin 2 converting enzyme (ACE2) protect against cerebral malaria in Indian adults. Infect Genet Evol. 2010;10:337\u201341.","journal-title":"Infect Genet Evol"},{"key":"6701_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2174\/1871526514666140713152858","volume":"14","author":"D Strayer","year":"2014","unstructured":"Strayer D, Dickey R, Carter W. Sensitivity of SARS\/MERS CoV to interferons and other drugs based on achievable serum concentrations in humans. Infect Disord Drug Targets. 2014;14:37\u201343.","journal-title":"Infect Disord Drug Targets"},{"key":"6701_CR23","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1056\/NEJMe2002387","volume":"382","author":"AS Fauci","year":"2020","unstructured":"Fauci AS, Lane HC, Redfield RR. COVID-19\u2014navigating the uncharted. N Engl J Med. 2020;382:1268\u20139.","journal-title":"N Engl J Med"},{"key":"6701_CR24","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1056\/NEJMoa2016638","volume":"383","author":"DR Boulware","year":"2020","unstructured":"Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19. N Engl J Med. 2020;383:517\u201325.","journal-title":"N Engl J Med"},{"key":"6701_CR25","unstructured":"NIAIDS. Evaluating the efficacy of hydroxychloroquine and azithromycin to prevent hospitalization or death in persons with COVID-19. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04358068  Accessed 2020."},{"key":"6701_CR26","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","volume":"3","author":"A Savarino","year":"2003","unstructured":"Savarino A, Boelaert JR, Cassone A, Majori G, Cauda R. Effects of chloroquine on viral infections: an old drug against today\u2019s diseases. Lancet Infect Dis. 2003;3:722\u20137.","journal-title":"Lancet Infect Dis"},{"key":"6701_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1743-422X-2-69","volume":"2","author":"MJ Vincent","year":"2005","unstructured":"Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG. Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J. 2005;2:69.","journal-title":"Virol J"},{"key":"6701_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/tropicalmed5030141","volume":"5","author":"DG Francesco","year":"2020","unstructured":"Francesco DG, Claudia M, Pietro L, Damiano P, Giovanni P. Malaria and COVID-19: common and different findings. Trop Med Infect Dis. 2020;5:141.","journal-title":"Trop Med Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06701-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-021-06701-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-021-06701-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T11:02:37Z","timestamp":1632049357000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-021-06701-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,19]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["6701"],"URL":"https:\/\/doi.org\/10.1186\/s12879-021-06701-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,19]]},"assertion":[{"value":"21 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval from institutional review board was not sought for this study due to the use of publicly available data from open resources.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"975"}}